Spots Global Cancer Trial Database for docetaxel injection
Every month we try and update this database with for docetaxel injection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer | NCT05673590 | Locally Advance... | Utidelone Injec... Docetaxel Injec... | 18 Years - 70 Years | Beijing Biostar Pharmaceuticals Co., Ltd. | |
| A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma | NCT04385550 | Advanced Gastri... | Anlotinib hydro... AK105 injection Paclitaxel inje... Docetaxel injec... | 18 Years - 75 Years | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC） | NCT06107673 | Breast Cancer | Dalpiciclib Aromatase inhib... Docetaxel injec... Epirubicin Hydr... Cyclophosphamid... | 18 Years - 75 Years | Hebei Medical University Fourth Hospital | |
| Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage | NCT05627752 | Prostate Cancer Castrate Resist... | Enzalutamide 40... Docetaxel injec... | 18 Years - 75 Years | Zhongnan Hospital | |
| Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer | NCT05673590 | Locally Advance... | Utidelone Injec... Docetaxel Injec... | 18 Years - 70 Years | Beijing Biostar Pharmaceuticals Co., Ltd. | |
| Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer | NCT04869371 | Neoadjuvant The... | Docetaxel injec... Triptorelin Pam... Prednisone Acet... | 18 Years - 75 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus. | NCT05481645 | Advanced Endome... Sarcoma of Uter... | TQB2450 injecti... Anlotinib Hydro... Carboplatin Inj... Paclitaxel Inje... Doxorubicin Hyd... Gemcitabine Hyd... Docetaxel injec... | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours | NCT04889599 | Docetaxel Solid Tumours Bioequivalence | BH009 (Docetaxe... Docetaxel injec... | 18 Years - | Zhuhai Beihai Biotech Co., Ltd | |
| Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC） | NCT06107673 | Breast Cancer | Dalpiciclib Aromatase inhib... Docetaxel injec... Epirubicin Hydr... Cyclophosphamid... | 18 Years - 75 Years | Hebei Medical University Fourth Hospital | |
| Phase Ⅱ/Ⅲ Clinical Study of Tumor Treating Fields （EFE-P100）Combined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With Disease Progression After Platinum-based Chemotherapy and Anti-programmed Death 1（PD-1)/Programmed Cell Death-Ligand 1(PD-L1) Antibody Treatment | NCT05661240 | Non-small Cell ... | Tumor treating ... Docetaxel injec... | 18 Years - 80 Years | Jiangsu Healthy Life Innovation Medical Technology Co., Ltd | |
| A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer | NCT05754853 | Advanced or Met... | MRG002 Docetaxel Injec... Paclitaxel Inje... Gemcitabine Hyd... Pemetrexed Diso... | 18 Years - 75 Years | Shanghai Miracogen Inc. | |
| D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure | NCT06300177 | Non Small Cell ... | D-1553 Tablet Docetaxel injec... | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus. | NCT05481645 | Advanced Endome... Sarcoma of Uter... | TQB2450 injecti... Anlotinib Hydro... Carboplatin Inj... Paclitaxel Inje... Doxorubicin Hyd... Gemcitabine Hyd... Docetaxel injec... | 18 Years - | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | |
| SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and Chemotherapy | NCT04878107 | Non-Small Cell ... | Camrelizumab Apatinib Docetaxel injec... SBRT LDRT | 18 Years - 75 Years | Wuhan University | |
| Phase Ⅱ/Ⅲ Clinical Study of Tumor Treating Fields （EFE-P100）Combined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With Disease Progression After Platinum-based Chemotherapy and Anti-programmed Death 1（PD-1)/Programmed Cell Death-Ligand 1(PD-L1) Antibody Treatment | NCT05661240 | Non-small Cell ... | Tumor treating ... Docetaxel injec... | 18 Years - 80 Years | Jiangsu Healthy Life Innovation Medical Technology Co., Ltd | |
| JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects | NCT06079983 | Breast Cancer | JSKN003 Capecitabine ta... Gemcitabine hyd... Vinorelbine tar... Paclitaxel for ... Docetaxel injec... Eribulin mesyla... | 18 Years - | Jiangsu Alphamab Biopharmaceuticals Co., Ltd |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
